OpenVSafe by OpenVAERS
Search V-safe

YCP-30437-45315

4 vaccinations 16 coded responses 29 check-ins 15 free-text entries 8 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
970 / OR
Registered
2021-03-19
Relationship
Self
Race
Other
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2280809 (opens in a new window) low 10 / 11 10 3 of 7 VAERS symptoms same dose (4) OR matches 2022-04-15 / 2022-05-05 / 2022-05-17
received the same day as the last call
case 683692

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-03-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-03-30
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  6. 2021-04-01
    Dose 2 — Pfizer-BioNTech
  7. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · None
    Adult check-in
  8. 2021-04-08
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-23
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  11. 2021-04-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-06
    Survey response — day 35, dose 2
    MedDRA: Decreased appetite, Nausea — Feeling: Fair
    Free text: I'm nauseous and my appetite is poor.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-14
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-07-06
    Survey response — 3 months, dose 2
    MedDRA: Rash — Feeling: Poor
    Free text: Rash
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-09-11
    Dose 3 — Pfizer-BioNTech
  16. 2021-10-06
    Survey response — 6 months, dose 2
    MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Discovered I had Hep B in my past. My MS symptoms have worsened.
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-10-06
    Survey response — day 21, dose 3
    MedDRA: Fatigue, Office visit, Parosmia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Increased fatigue and a weird odor in my nose. · Healthcare visit (other): Med office visit.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-10-06
    Report sent to call center — day 21, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  19. 2021-10-15
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  20. 2021-10-17
    Survey response — day 35, dose 3
    MedDRA: Hepatitis B, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: DX w/Hep B. · Healthcare visit (other): Labs and doctor. And HepAB vax.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-10-17
    Report sent to call center — day 35, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-10-19
  23. 2021-11-03
  24. 2022-03-12
    Survey response — 6 months, dose 3
    MedDRA: Peripheral arterial occlusive disease, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: PAD · Healthcare visit (other): Imaging
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-03-12
    Report sent to call center — 6 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2022-03-14
    Call successful
    Completed over the phone
  27. 2022-04-15
    Dose 4 — Pfizer-BioNTech
  28. 2022-04-17
    Survey response — days 1–6 daily, dose 4
    MedDRA: Aortic arteriosclerosis, Peripheral arterial occlusive disease — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: New dx of left leg artery w/plaque and in my heart.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-04-18
    Survey response — days 1–6 daily, dose 4
    MedDRA: Fatigue — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Rundown
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-04-19
    Survey response — days 1–6 daily, dose 4
    MedDRA: Fatigue — Feeling: Poor · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Free text: I'm exhausted today!
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-04-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  32. 2022-04-22
    Health check-in — day 7, dose 4
    Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  33. 2022-04-29
    Survey response — day 14, dose 4
    MedDRA: Abdominal pain upper, Myalgia, Pruritus — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Stomach hurts, still itching, muscle aches
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-05-06
    Survey response — day 21, dose 4
    MedDRA: Fatigue, Haemorrhage, Thrombosis — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Heavy bleeding w/clots. I don't know where from. It started suddenly and I bled for about 20 min. faster than I could clean the floor! I'm exhausted today.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-05-13
    Survey response — day 28, dose 4
    MedDRA: Office visit, Rectal haemorrhage, Sinusitis, Vaginal haemorrhage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Bleeding w/clots from my rectum or vagina! Sinus infection. · Healthcare visit (other): Labs, urine test, appt
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-05-13
    Report sent to call center — day 28, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  37. 2022-05-16
  38. 2022-05-17
    Call successful
    Completed over the phone
  39. 2022-05-17
    Call successful
    Completed over the phone
  40. 2022-05-17
    Call successful
    Completed over the phone
  41. 2022-05-20
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  42. 2022-05-27
    Survey response — day 42, dose 4
    MedDRA: Haemorrhage, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Bleeding excessively from either my bladder or rectum. · Healthcare visit (other): Ultrasound
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-05-27
    Report sent to call center — day 42, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  44. 2022-06-01
  45. 2022-07-15
    Survey response — 3 months, dose 4
    MedDRA: COVID-19, Rectal haemorrhage — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Rectal bleeding, COVID and the aftermath of it!
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-07-15
    Report sent to call center — 3 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  47. 2022-07-18
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  48. 2022-07-18
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  49. 2022-10-14
    Survey response — 6 months, dose 4
    MedDRA: Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Long COVID
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-10-14
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  51. 2022-10-17
  52. 2023-04-17
    Survey response — 12 months, dose 4
    MedDRA: Office visit, Post-acute COVID-19 syndrome — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2024-11
  53. 2023-04-17
    Report sent to call center — 12 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  54. 2023-04-19
  55. 2023-04-19
  56. 2023-05-17
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Pfizer-BioNTech
22021-04-01Pfizer-BioNTech
32021-09-11Pfizer-BioNTech No
42022-04-15Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-10-06 Successful
2022-05-17
Completed over the phone
2021-10-17 Successful
2022-05-17
Completed over the phone
2022-03-12 Successful
2022-03-14
Completed over the phone
2022-05-13 Successful
2022-05-17
Completed over the phone
2022-05-27 Successful
2022-07-18
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-07-15 Successful
2022-07-18
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-14 Unsuccessful Reported to VAERS during previous contact from GDIT
2023-04-17 Successful
2023-05-17
Reported to VAERS during previous contact from GDIT

Free text

Release 8 — day 35, dose 2

2021-05-06

Symptoms: I'm nauseous and my appetite is poor.

Release 9 — 3 months, dose 2

2021-07-06

Symptoms: Rash

Release 10 — 6 months, dose 2

2021-10-06

Symptoms: Discovered I had Hep B in my past. My MS symptoms have worsened.

Release 10 — day 21, dose 3

2021-10-06

Symptoms: Increased fatigue and a weird odor in my nose.
Healthcare visit (other): Med office visit.

Release 10 — day 35, dose 3

2021-10-17

Symptoms: DX w/Hep B.
Healthcare visit (other): Labs and doctor. And HepAB vax.

Release 11 — 6 months, dose 3

2022-03-12

Symptoms: PAD
Healthcare visit (other): Imaging

Release 11 — days 1–6 daily, dose 4

2022-04-17

Systemic reaction (other): New dx of left leg artery w/plaque and in my heart.

2022-04-18

Systemic reaction (other): Rundown

2022-04-19

Systemic reaction (other): I'm exhausted today!

Release 11 — day 14, dose 4

2022-04-29

Symptoms: Stomach hurts, still itching, muscle aches

Release 11 — day 21, dose 4

2022-05-06

Symptoms: Heavy bleeding w/clots. I don't know where from. It started suddenly and I bled for about 20 min. faster than I could clean the floor! I'm exhausted today.

Release 11 — day 28, dose 4

2022-05-13

Symptoms: Bleeding w/clots from my rectum or vagina! Sinus infection.
Healthcare visit (other): Labs, urine test, appt

Release 11 — day 42, dose 4

2022-05-27

Symptoms: Bleeding excessively from either my bladder or rectum.
Healthcare visit (other): Ultrasound

Release 12 — 3 months, dose 4

2022-07-15

Symptoms: Rectal bleeding, COVID and the aftermath of it!

Release 12 — 6 months, dose 4

2022-10-14

Symptoms: Long COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOUnevaluable event · · ✓
SDAbdominal pain upper · · ✓
SDCOVID-19 · · ✓
SDDecreased appetite ✓ ✓ ✓
SDFatigue · · ✓
SDHaemorrhage · · ✓
SDHepatitis B · · ✓
SDMultiple sclerosis · · ✓
SDMyalgia · · ✓
SDNausea ✓ ✓ ✓
SDParosmia · · ✓
SDPeripheral arterial occlusive disease · · ✓
SDPost-acute COVID-19 syndrome · · ✓
SDPre-existing disease · · ✓
SDPruritus · · ✓
SDRash ✓ ✓ ✓
SDRectal haemorrhage · · ✓
SDSinusitis · · ✓
SDThrombosis · · ✓
SDVaginal haemorrhage · · ✓
SROAortic arteriosclerosis · · ✓
SROFatigue · · ✓
SROPeripheral arterial occlusive disease · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release